Latest news
Merck & Co., Inc. 2026: Revenue $16.61B, EPS ($0.54) — 10-Q Summary - TradingViewTradingView · Fri, 07 Aug 2026 20:23:58 GMTMerck KGaA Q2 Earnings Call Highlights - TradingViewTradingView · Thu, 06 Aug 2026 14:04:22 GMTMerck KGaA raises profit guidance on momentum in Life Science, Electronics units - TradingViewTradingView · Thu, 06 Aug 2026 05:00:00 GMTKey facts: Merck & Co., Inc. Q2 Sales $16.6B; sac-TMT Advances - TradingViewTradingView · Wed, 05 Aug 2026 07:14:57 GMTMRK Q2 Earnings & Sales Beat Estimates, '26 Sales View Raised - TradingViewTradingView · Tue, 04 Aug 2026 17:45:00 GMTMerck posts better-than-expected second-quarter results on Keytruda strength - TradingViewTradingView · Tue, 04 Aug 2026 12:10:51 GMTMerck (NYSE:MRK) Posts Better-Than-Expected Sales In Q2 CY2026 - TradingViewTradingView · Tue, 04 Aug 2026 10:59:42 GMTMerck reports Q2 2026 sales $16.6B, GAAP loss $0.54/sh; narrows FY26 sales to $66.3–$67.3B - TradingViewTradingView · Tue, 04 Aug 2026 10:53:01 GMT